Related references
Note: Only part of the references are listed.NAADP+ is an agonist of the human P2Y11 purinergic receptor
Iliana Moreschi et al.
CELL CALCIUM (2008)
Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor
Kathryn R. Vaughan et al.
JOURNAL OF IMMUNOLOGY (2007)
Platelet-derived nitric oxide signaling and regulation
Eugenia Gkaliagkousi et al.
CIRCULATION RESEARCH (2007)
Mitochondrial dysfunction induced by a cytotoxic adenine dinucleotide produced by ADP-ribosyl cyclases from cADPR
Santina Bruzzone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes
Iliana Moreschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
[32P]2-iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors
D Houston et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation
JA Marjanovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency
H Ullmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The P2 receptors in platelet function
B Hechler et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
The platelet P2 receptors in thrombosis
C Gachet et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors
Y Chen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Nitric oxide insufficiency and atherothrombosis
B Voetsch et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Quantification of ADP and ATP receptor expression in human platelets
L Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
The relative importance of the ADP receptors, P2Y(12) and P2Y(1), in thrombin-induced platelet activation
S Nylander et al.
THROMBOSIS RESEARCH (2003)
Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs
JE Keeble et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
A novel cycling assay for nicotinic acid-adenine dinucleotide phosphate with nanomolar sensitivity
R Graeff et al.
BIOCHEMICAL JOURNAL (2002)
Modulation of L-arginine transport and nitric oxide production by gabexate mesylate
G Leoncini et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Adenosine increases human platelet levels of cGMP through nitric oxide - Possible role in its antiaggregating effect
G Anfossi et al.
THROMBOSIS RESEARCH (2002)
Nitric oxide insufficiency, platelet activation, and arterial thrombosis
J Loscalzo
CIRCULATION RESEARCH (2001)
Dinucleotides as growth-promoting extracellular mediators -: Presence of dinucleoside diphosphates Ap2A, Ap2G, and Gp2G in releasable granules of platelets
J Jankowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase
AD Qi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
